NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Relationship Between Serum Apolipoprotein Levels and Weight Loss in Patients Undergoing Sleeve Gastrectomy for Morbid Obesity

NCT07325916

CompletedN/A

Sponsor: Yigit DUZKOYLU

Conditions: Morbid Obesity Requiring Bariatric Surgery

Interventions: Laparoscopic Sleeve Gastrectomy

Countries: Turkey (Türkiye)

The study looks at whether a specific protein in the blood, called apolipoprotein, can predict how much weight a person might lose after sleeve gastrectomy, a surgery for people with severe obesity. We want to find a specific level of this protein that shows which patients are most likely to lose weight successfully after surgery. By identifying this level, we hope to guide doctors in deciding who should have the surgery and who might do better with non-surgical weight loss methods.

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients aged 18 to 75
* International Classification of Diseases (ICD) code E66 diagnosis (obesity)
* Patients who have given consent for sleeve gastrectomy
* Patients who are suitable for general anesthesia

Exclusion Criteria:

* Patients who did not give consent to be included in the study
* Patients who are scheduled for surgery other than sleeve gastrectomy

Locations (1)

Istanbul, Basaksehir, Turkey (Türkiye)